The impact of epigenetic features on breast cancer treatment and outcomes

Last month, Ju­dith Ng-Cashin be­came Novotech’s first chief med­ical of­fi­cer, with an eye to­ward ex­pand­ing the Asia-Pa­cif­ic con­tract re­search or­ga­ni­za­tion (CRO) far­ther West. Ng-Cashin, who

On the back of re­port­ing megablock­buster sales of We­govy, No­vo Nordisk has snapped up In­ver­sa­go Phar­ma for up to $1.075 bil­lion in a deal that